Authors: MONTELLO MJ GREENBLATT JJ FALLAVOLLITA A SHOEMAKER D

Citation: Mj. Montello et al., ACCESSING INVESTIGATIONAL ANTICANCER AGENTS OUTSIDE OF CLINICAL-TRIALS, American journal of health-system pharmacy, 55(7), 1998, pp. 651

Authors: KOHLER DR MONTELLO MJ GREEN L HUNTLEY C HIGH JL FALLAVOLLITA A GOLDSPIEL BR

Citation: Dr. Kohler et al., STANDARDIZING THE EXPRESSION AND NOMENCLATURE OF CANCER-TREATMENT REGIMENS, American journal of health-system pharmacy, 55(2), 1998, pp. 137-144

Authors: CHESON BD SORENSEN JM VENA DA MONTELLO MJ BARRET JA DAMASIO E TALLMAN M ANNINO L CONNERS J COIFFIER B LAURIA F

Citation: Bd. Cheson et al., TREATMENT OF HAIRY-CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE VIA THE GROUP-C PROTOCOL MECHANISM OF THE NATIONAL-CANCER-INSTITUTE - A REPORTOF 979 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 3007-3015

Authors: WIDEMANN BC BALIS FM MURPHY RF SORENSEN JM MONTELLO MJ OBRIEN M ADAMSON PC

Citation: Bc. Widemann et al., CARBOXYPEPTIDASE-G(2), THYMIDINE, AND LEUCOVORIN RESCUE IN CANCER-PATIENTS WITH METHOTREXATE-INDUCED RENAL DYSFUNCTION, Journal of clinical oncology, 15(5), 1997, pp. 2125-2134

Authors: BALTZ JK MONTELLO MJ

Citation: Jk. Baltz et Mj. Montello, CLADRIBINE FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES, Clinical pharmacy, 12(11), 1993, pp. 805-813